chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 19.0
Sex: M
Vaccine: FLUX, MMR, SMALL, FLUX, MMR, SMALL
Symptoms: Nodule
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382698. A 19-year-old male patient received the following vaccinations 03 March 2010: a percutaneous (15 jab) ACAM2000 (lot number LL04-003-A); Influenza (seasonal) vaccine (trade name, manufacturer name and lot number unknown); and a first dose measles, mumps, rubella vaccine (other manufacturer, trade name and lot number unknown). Medical history was not reported. Per the reporter, the patient was vaccinated in the left deltoid; however it was not identified if all vaccines, or just one vaccine was administered in this area. Five days after vaccination the patient developed a small nodule to the left side of the neck, then noted nodule on the top of his head and right side of his neck. The patient was re-educated. Recovery status was not reported. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Erythema, Pruritus
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382764.  A 22-year-old male patient received ACAM2000 (lot number W04003A) on 11 February 2010.  Approximately 10 minutes post-vaccination, the patient developed sudden onset redness and itching of the face, ears, and arms.  He was treated with 25mg of intramuscular BENADRYL, and symptoms resolved within 20 minutes of administration.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Cough, Erythema, Eye pain, Headache, Injection site erythema
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382898.  A 23-year-old female patient received a left deltoid percutaneous dose of ACAM2000 (lot number not reported) on 04 March 2010.  Seven days after vaccination, the patient had 3 day onset of increasing injection site redness with streaking, axillary swelling and tenderness, and headache.  The patient advised she had a mild cold (runny nose) when given the vaccine and had experienced this on and off for a few months.  The patient reported she had a normal take of the smallpox vaccine with pustule until 11 March 2010 she noted increased swelling/tenderness to left axillary region (nodes), injection site itching, redness and oozing, and mild ache to the top of her left shoulder (pointed to trapezius muscle).  Two days later, she began to feel warm (no fever), and had a sore throat, runny nose, and her ears were popping (similar to past colds).  She had a dull headache to the top of her head/forehead that was worse; and her eyes hurt to move.  She denied any nausea, vomiting, diarrhea, photo/phonophobia, shortness of breath, chest pain, limitation in range of motion of left arm, neck pain, or any paresthesia in the left arm.  The following day the redness had extended past the dressing site and was streaking to the axillary area.  There was no change in her headache or shoulder discomfort.  She slept all day.  The patient reported to medical on 15 March 2010 concerned about the injection site redness and streaking.  She took 1600 mg of Motrin for her headache and shoulder pain with improvement.  She had symptoms of edema at injection site less than 30mm, headache, general joint pain (isolated), erythema and pruritis.  The patient recovered.  Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Injection site oedema, Injection site pain, Injection site pruritus, Injection site streaking, Oropharyngeal pain
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382898.  A 23-year-old female patient received a left deltoid percutaneous dose of ACAM2000 (lot number not reported) on 04 March 2010.  Seven days after vaccination, the patient had 3 day onset of increasing injection site redness with streaking, axillary swelling and tenderness, and headache.  The patient advised she had a mild cold (runny nose) when given the vaccine and had experienced this on and off for a few months.  The patient reported she had a normal take of the smallpox vaccine with pustule until 11 March 2010 she noted increased swelling/tenderness to left axillary region (nodes), injection site itching, redness and oozing, and mild ache to the top of her left shoulder (pointed to trapezius muscle).  Two days later, she began to feel warm (no fever), and had a sore throat, runny nose, and her ears were popping (similar to past colds).  She had a dull headache to the top of her head/forehead that was worse; and her eyes hurt to move.  She denied any nausea, vomiting, diarrhea, photo/phonophobia, shortness of breath, chest pain, limitation in range of motion of left arm, neck pain, or any paresthesia in the left arm.  The following day the redness had extended past the dressing site and was streaking to the axillary area.  There was no change in her headache or shoulder discomfort.  She slept all day.  The patient reported to medical on 15 March 2010 concerned about the injection site redness and streaking.  She took 1600 mg of Motrin for her headache and shoulder pain with improvement.  She had symptoms of edema at injection site less than 30mm, headache, general joint pain (isolated), erythema and pruritis.  The patient recovered.  Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Pruritus, Rhinorrhoea, Skin warm, Swelling, Tenderness
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382898.  A 23-year-old female patient received a left deltoid percutaneous dose of ACAM2000 (lot number not reported) on 04 March 2010.  Seven days after vaccination, the patient had 3 day onset of increasing injection site redness with streaking, axillary swelling and tenderness, and headache.  The patient advised she had a mild cold (runny nose) when given the vaccine and had experienced this on and off for a few months.  The patient reported she had a normal take of the smallpox vaccine with pustule until 11 March 2010 she noted increased swelling/tenderness to left axillary region (nodes), injection site itching, redness and oozing, and mild ache to the top of her left shoulder (pointed to trapezius muscle).  Two days later, she began to feel warm (no fever), and had a sore throat, runny nose, and her ears were popping (similar to past colds).  She had a dull headache to the top of her head/forehead that was worse; and her eyes hurt to move.  She denied any nausea, vomiting, diarrhea, photo/phonophobia, shortness of breath, chest pain, limitation in range of motion of left arm, neck pain, or any paresthesia in the left arm.  The following day the redness had extended past the dressing site and was streaking to the axillary area.  There was no change in her headache or shoulder discomfort.  She slept all day.  The patient reported to medical on 15 March 2010 concerned about the injection site redness and streaking.  She took 1600 mg of Motrin for her headache and shoulder pain with improvement.  She had symptoms of edema at injection site less than 30mm, headache, general joint pain (isolated), erythema and pruritis.  The patient recovered.  Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Tinnitus
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382898.  A 23-year-old female patient received a left deltoid percutaneous dose of ACAM2000 (lot number not reported) on 04 March 2010.  Seven days after vaccination, the patient had 3 day onset of increasing injection site redness with streaking, axillary swelling and tenderness, and headache.  The patient advised she had a mild cold (runny nose) when given the vaccine and had experienced this on and off for a few months.  The patient reported she had a normal take of the smallpox vaccine with pustule until 11 March 2010 she noted increased swelling/tenderness to left axillary region (nodes), injection site itching, redness and oozing, and mild ache to the top of her left shoulder (pointed to trapezius muscle).  Two days later, she began to feel warm (no fever), and had a sore throat, runny nose, and her ears were popping (similar to past colds).  She had a dull headache to the top of her head/forehead that was worse; and her eyes hurt to move.  She denied any nausea, vomiting, diarrhea, photo/phonophobia, shortness of breath, chest pain, limitation in range of motion of left arm, neck pain, or any paresthesia in the left arm.  The following day the redness had extended past the dressing site and was streaking to the axillary area.  There was no change in her headache or shoulder discomfort.  She slept all day.  The patient reported to medical on 15 March 2010 concerned about the injection site redness and streaking.  She took 1600 mg of Motrin for her headache and shoulder pain with improvement.  She had symptoms of edema at injection site less than 30mm, headache, general joint pain (isolated), erythema and pruritis.  The patient recovered.  Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Arthralgia, Erythema, Eye pain, Feeling hot, Headache
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382898.  A 23-year-old female patient received a left deltoid percutaneous dose of ACAM2000 (lot number not reported) on 04 March 2010.  Seven days after vaccination, the patient had 3 day onset of increasing injection site redness with streaking, axillary swelling and tenderness, and headache.  The patient advised she had a mild cold (runny nose) when given the vaccine and had experienced this on and off for a few months.  The patient reported she had a normal take of the smallpox vaccine with pustule until 11 March 2010 she noted increased swelling/tenderness to left axillary region (nodes), injection site itching, redness and oozing, and mild ache to the top of her left shoulder (pointed to trapezius muscle).  Two days later, she began to feel warm (no fever), and had a sore throat, runny nose, and her ears were popping (similar to past colds).  She had a dull headache to the top of her head/forehead that was worse; and her eyes hurt to move.  She denied any nausea, vomiting, diarrhea, photo/phonophobia, shortness of breath, chest pain, limitation in range of motion of left arm, neck pain, or any paresthesia in the left arm.  The following day the redness had extended past the dressing site and was streaking to the axillary area.  There was no change in her headache or shoulder discomfort.  She slept all day.  The patient reported to medical on 15 March 2010 concerned about the injection site redness and streaking.  She took 1600 mg of Motrin for her headache and shoulder pain with improvement.  She had symptoms of edema at injection site less than 30mm, headache, general joint pain (isolated), erythema and pruritis.  The patient recovered.  Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Injection site erythema, Injection site oedema, Injection site pruritus, Injection site reaction, Injection site streaking
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382898.  A 23-year-old female patient received a left deltoid percutaneous dose of ACAM2000 (lot number not reported) on 04 March 2010.  Seven days after vaccination, the patient had 3 day onset of increasing injection site redness with streaking, axillary swelling and tenderness, and headache.  The patient advised she had a mild cold (runny nose) when given the vaccine and had experienced this on and off for a few months.  The patient reported she had a normal take of the smallpox vaccine with pustule until 11 March 2010 she noted increased swelling/tenderness to left axillary region (nodes), injection site itching, redness and oozing, and mild ache to the top of her left shoulder (pointed to trapezius muscle).  Two days later, she began to feel warm (no fever), and had a sore throat, runny nose, and her ears were popping (similar to past colds).  She had a dull headache to the top of her head/forehead that was worse; and her eyes hurt to move.  She denied any nausea, vomiting, diarrhea, photo/phonophobia, shortness of breath, chest pain, limitation in range of motion of left arm, neck pain, or any paresthesia in the left arm.  The following day the redness had extended past the dressing site and was streaking to the axillary area.  There was no change in her headache or shoulder discomfort.  She slept all day.  The patient reported to medical on 15 March 2010 concerned about the injection site redness and streaking.  She took 1600 mg of Motrin for her headache and shoulder pain with improvement.  She had symptoms of edema at injection site less than 30mm, headache, general joint pain (isolated), erythema and pruritis.  The patient recovered.  Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Lymph node pain, Lymphadenopathy, Musculoskeletal pain, Oropharyngeal pain, Pruritus
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382898.  A 23-year-old female patient received a left deltoid percutaneous dose of ACAM2000 (lot number not reported) on 04 March 2010.  Seven days after vaccination, the patient had 3 day onset of increasing injection site redness with streaking, axillary swelling and tenderness, and headache.  The patient advised she had a mild cold (runny nose) when given the vaccine and had experienced this on and off for a few months.  The patient reported she had a normal take of the smallpox vaccine with pustule until 11 March 2010 she noted increased swelling/tenderness to left axillary region (nodes), injection site itching, redness and oozing, and mild ache to the top of her left shoulder (pointed to trapezius muscle).  Two days later, she began to feel warm (no fever), and had a sore throat, runny nose, and her ears were popping (similar to past colds).  She had a dull headache to the top of her head/forehead that was worse; and her eyes hurt to move.  She denied any nausea, vomiting, diarrhea, photo/phonophobia, shortness of breath, chest pain, limitation in range of motion of left arm, neck pain, or any paresthesia in the left arm.  The following day the redness had extended past the dressing site and was streaking to the axillary area.  There was no change in her headache or shoulder discomfort.  She slept all day.  The patient reported to medical on 15 March 2010 concerned about the injection site redness and streaking.  She took 1600 mg of Motrin for her headache and shoulder pain with improvement.  She had symptoms of edema at injection site less than 30mm, headache, general joint pain (isolated), erythema and pruritis.  The patient recovered.  Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Rhinorrhoea, Somnolence, Tinnitus, Wound secretion
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382898.  A 23-year-old female patient received a left deltoid percutaneous dose of ACAM2000 (lot number not reported) on 04 March 2010.  Seven days after vaccination, the patient had 3 day onset of increasing injection site redness with streaking, axillary swelling and tenderness, and headache.  The patient advised she had a mild cold (runny nose) when given the vaccine and had experienced this on and off for a few months.  The patient reported she had a normal take of the smallpox vaccine with pustule until 11 March 2010 she noted increased swelling/tenderness to left axillary region (nodes), injection site itching, redness and oozing, and mild ache to the top of her left shoulder (pointed to trapezius muscle).  Two days later, she began to feel warm (no fever), and had a sore throat, runny nose, and her ears were popping (similar to past colds).  She had a dull headache to the top of her head/forehead that was worse; and her eyes hurt to move.  She denied any nausea, vomiting, diarrhea, photo/phonophobia, shortness of breath, chest pain, limitation in range of motion of left arm, neck pain, or any paresthesia in the left arm.  The following day the redness had extended past the dressing site and was streaking to the axillary area.  There was no change in her headache or shoulder discomfort.  She slept all day.  The patient reported to medical on 15 March 2010 concerned about the injection site redness and streaking.  She took 1600 mg of Motrin for her headache and shoulder pain with improvement.  She had symptoms of edema at injection site less than 30mm, headache, general joint pain (isolated), erythema and pruritis.  The patient recovered.  Documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Cardiac enzymes normal, Chest pain, Electrocardiogram normal, Injection site vesicles, Musculoskeletal chest pain
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 383794.  A 23-year-old male patient received ACAM2000 (lot number VV04-003A) on 05 February 2010.  Seven days post-vaccination, on 12 February 2010, he reported pleuritic discomfort and chest pain that was brought on by inspiration and movement.  He was referred to the emergency department; cardiac enzymes were negative, and an ECG was normal.  The injection site had formed a normal blister, and he denied any other constitutional symptoms.  He was diagnosed with musculoskeletal chest pain, and reported feeling well by 26 February 2010.  Documents held by sender: none.
Age: 23.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pleuritic pain
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 383794.  A 23-year-old male patient received ACAM2000 (lot number VV04-003A) on 05 February 2010.  Seven days post-vaccination, on 12 February 2010, he reported pleuritic discomfort and chest pain that was brought on by inspiration and movement.  He was referred to the emergency department; cardiac enzymes were negative, and an ECG was normal.  The injection site had formed a normal blister, and he denied any other constitutional symptoms.  He was diagnosed with musculoskeletal chest pain, and reported feeling well by 26 February 2010.  Documents held by sender: none.
Age: 23.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pain, Painful respiration, Pleuritic pain
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 383794.  A 23-year-old male patient received ACAM2000 (lot number VV04-003A) on 05 February 2010.  Seven days post-vaccination, on 12 February 2010, he reported pleuritic discomfort and chest pain that was brought on by inspiration and movement.  He was referred to the emergency department; cardiac enzymes were negative, and an ECG was normal.  The injection site had formed a normal blister, and he denied any other constitutional symptoms.  He was diagnosed with musculoskeletal chest pain, and reported feeling well by 26 February 2010.  Documents held by sender: none.
Age: 29.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Polymerase chain reaction, Secondary transmission, Vaccinia test positive, Vaccinia virus infection
Clinical narrative: Initial report received on 30 July 2010 via a Qscan search on the VAERS database, under reference number 383935. This case involves tertiary spread of vaccinia due to inadvertent inoculation. A 29 year-old female patient was hospitalized after she developed secondary transmission of vaccinia virus infection on 09 March 2010. The patient's brother was a secondary case exposed to a an individual who had received ACAM2000 (lot number not reported) on an unspecified date. The brother had been exposed during a sports match on 27 February 2010. The patient was a household contact with her brother. On 16 March 2010, the patient had vesicles that were positive for vaccina by rt-PCR lab. The patient's recovery status was not reported. VAERS noted that follow-up on 13 May 2010 indicated this 29 year-old female patient had developed vaccina from the same individual mentioned in VAERS report with ID numbers 384016 (patient's brother, case number 2010-04090), 384017 (unidentified), and 384018 (unidentified). This report pertains to the 29 year-old female patient. This case was coded as secondary transmission despite the reported term of tertiary transmission due to coding limitations. Information regarding her brother (a case of secondary transmission) is reported in case number 2010-04090. Documents held by sender: None
Age: 29.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Blister, Polymerase chain reaction, Secondary transmission, Vaccinia test positive, Vaccinia virus infection
Clinical narrative: Initial report received on 30 July 2010 via a Qscan search on the VAERS database, under reference number 383935. This case involves tertiary spread of vaccinia due to inadvertent inoculation. A 29 year-old female patient was hospitalized after she developed secondary transmission of vaccinia virus infection on 09 March 2010. The patient's brother was a secondary case exposed to a an individual who had received ACAM2000 (lot number not reported) on an unspecified date. The brother had been exposed during a sports match on 27 February 2010. The patient was a household contact with her brother. On 16 March 2010, the patient had vesicles that were positive for vaccina by rt-PCR lab. The patient's recovery status was not reported. VAERS noted that follow-up on 13 May 2010 indicated this 29 year-old female patient had developed vaccina from the same individual mentioned in VAERS report with ID numbers 384016 (patient's brother, case number 2010-04090), 384017 (unidentified), and 384018 (unidentified). This report pertains to the 29 year-old female patient. This case was coded as secondary transmission despite the reported term of tertiary transmission due to coding limitations. Information regarding her brother (a case of secondary transmission) is reported in case number 2010-04090. Documents held by sender: None
Age: 25.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Skin lesion, Vaccinia test positive, Vaccinia virus infection
Clinical narrative: Initial report received on 30 July 2010 via a QScan search on the VAERS database, under reference number 384016.  A 25-year-old male patient required emergency room or doctor visit (ER) after he developed suspected vaccinia lesions on 01 March 2010.  The patient had been exposed during a wrestling match with a military person who had received a ACAM2000 (lot number not reported) on an unspecified date.  Specimens were collected from the patient and tested PCR positive for vaccinia.  The patient recovered.  The reporter for this case is the same for case number 2010-04089.  Documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Polymerase chain reaction, Secondary transmission, Skin lesion, Vaccinia test positive, Vaccinia virus infection
Clinical narrative: Initial report received on 30 July 2010 via a QScan search on the VAERS database, under reference number 384016.  A 25-year-old male patient required emergency room or doctor visit (ER) after he developed suspected vaccinia lesions on 01 March 2010.  The patient had been exposed during a wrestling match with a military person who had received a ACAM2000 (lot number not reported) on an unspecified date.  Specimens were collected from the patient and tested PCR positive for vaccinia.  The patient recovered.  The reporter for this case is the same for case number 2010-04089.  Documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Electrocardiogram abnormal
Clinical narrative: Initial report was received on 30 July 2010 via Q-Scan search of the VAERS database, under the reference number VAERS ID 384297. A 23-year-old male patient received the following vaccinations on 06 March 2010: ACAM2000 (lot number not reported). Nineteen days post vaccination (also reported as 18 days), on 25 March 2010, the patient experienced chest pain. The event required an emergency room or doctor's visit and an electrocardiogram was performed (dates not reported) which was abnormal. The patient's recovery status was not reported. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Lymphadenopathy, Neck pain, Pruritus, Rash erythematous, Rash generalised
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 385048.  A 22-year-old male patient received a percutaneous dose of ACAM2000 (lot number VV04-003) on 01 April 2010.  Eleven days after vaccination, the patient had a red rash on both arms, chest and back.  He stated rash worsened after wearing a new T-shirt he never washed.  The patient also experienced neck pain, lymphadenopathy, pruritus, and skin lesions the same day.  Recovery status was not reported.  Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Skin lesion
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 385048.  A 22-year-old male patient received a percutaneous dose of ACAM2000 (lot number VV04-003) on 01 April 2010.  Eleven days after vaccination, the patient had a red rash on both arms, chest and back.  He stated rash worsened after wearing a new T-shirt he never washed.  The patient also experienced neck pain, lymphadenopathy, pruritus, and skin lesions the same day.  Recovery status was not reported.  Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Lymphadenopathy, Neck pain, Pruritus, Rash, Rash erythematous
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 385048.  A 22-year-old male patient received a percutaneous dose of ACAM2000 (lot number VV04-003) on 01 April 2010.  Eleven days after vaccination, the patient had a red rash on both arms, chest and back.  He stated rash worsened after wearing a new T-shirt he never washed.  The patient also experienced neck pain, lymphadenopathy, pruritus, and skin lesions the same day.  Recovery status was not reported.  Documents held by sender: None.
Age: 32.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Unevaluable event
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 385050.  A 32-year-old male patient received a percutaneous dose of ACAM2000 (lot number W04-003) on 01 April 2010.  Nine day later, the patient had an unevaluable event and subsequently recovered on an unspecified date.  Documents held by sender: None.
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Unevaluable event
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 385051.  A male patient (date of birth not provided) received a first percutaneous dose of ACAM2000 (lot number VVV04-003) on 01 April 2010.  Nine days after vaccination, the patient had an unevaluable event.  He subsequently recovered on an unspecified date.  Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: SMALL, TD, SMALL, TTOX, ANTH, SMALL, TDAP, VARCEL, SMALL, TDAP, SMALL, TDAP
Symptoms: Chest discomfort, Electrocardiogram normal
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID# 387275. A 26 year-old female patient received the following vaccinations on 05 April 2010: ACAM2000 (lot number VV04003A), a right arm intramuscular injection of BOOSTRIX (lot number C3382AA). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no past medical history and no illness at the time of vaccination. She presented to the Emergency Room (ER) for shortness of breath (SOB) and orthopnea, 9 days (also reported as 2 days) after she received a small pox vaccination to the left arm prior to deployment. The patient noted a painful supraclavicular lymph node enlargement on the left. She noted having occasional chest pressure and cough without any sputum production plus night sweat. She denies fever, chills, vomiting, illicit drug use or recent travel. The patient was admitted to the cardiology service for the management of a suspected myopericarditis. Her cardiac enzymes were trended and all three sets were negative for acute coronary event. An echocardiogram and electrocardiogram were normal. The patient was started on low dose non-steroidal anti-inflammatory. The outcome was reported as unknown. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: SMALL, TD, SMALL, TTOX, ANTH, SMALL, TDAP, VARCEL, SMALL, TDAP, SMALL, TDAP
Symptoms: Chest discomfort, Dyspnoea, Echocardiogram normal, Electrocardiogram normal, Fatigue
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID# 387275. A 26 year-old female patient received the following vaccinations on 05 April 2010: ACAM2000 (lot number VV04003A), a right arm intramuscular injection of BOOSTRIX (lot number C3382AA). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no past medical history and no illness at the time of vaccination. She presented to the Emergency Room (ER) for shortness of breath (SOB) and orthopnea, 9 days (also reported as 2 days) after she received a small pox vaccination to the left arm prior to deployment. The patient noted a painful supraclavicular lymph node enlargement on the left. She noted having occasional chest pressure and cough without any sputum production plus night sweat. She denies fever, chills, vomiting, illicit drug use or recent travel. The patient was admitted to the cardiology service for the management of a suspected myopericarditis. Her cardiac enzymes were trended and all three sets were negative for acute coronary event. An echocardiogram and electrocardiogram were normal. The patient was started on low dose non-steroidal anti-inflammatory. The outcome was reported as unknown. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: SMALL, TD, SMALL, TTOX, ANTH, SMALL, TDAP, VARCEL, SMALL, TDAP, SMALL, TDAP
Symptoms: Hyperhidrosis, Laboratory test normal, Lymphadenopathy, Nausea, Troponin I
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID# 387275. A 26 year-old female patient received the following vaccinations on 05 April 2010: ACAM2000 (lot number VV04003A), a right arm intramuscular injection of BOOSTRIX (lot number C3382AA). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no past medical history and no illness at the time of vaccination. She presented to the Emergency Room (ER) for shortness of breath (SOB) and orthopnea, 9 days (also reported as 2 days) after she received a small pox vaccination to the left arm prior to deployment. The patient noted a painful supraclavicular lymph node enlargement on the left. She noted having occasional chest pressure and cough without any sputum production plus night sweat. She denies fever, chills, vomiting, illicit drug use or recent travel. The patient was admitted to the cardiology service for the management of a suspected myopericarditis. Her cardiac enzymes were trended and all three sets were negative for acute coronary event. An echocardiogram and electrocardiogram were normal. The patient was started on low dose non-steroidal anti-inflammatory. The outcome was reported as unknown. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: SMALL, TD, SMALL, TTOX, ANTH, SMALL, TDAP, VARCEL, SMALL, TDAP, SMALL, TDAP
Symptoms: Vaccination complication
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID# 387275. A 26 year-old female patient received the following vaccinations on 05 April 2010: ACAM2000 (lot number VV04003A), a right arm intramuscular injection of BOOSTRIX (lot number C3382AA). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no past medical history and no illness at the time of vaccination. She presented to the Emergency Room (ER) for shortness of breath (SOB) and orthopnea, 9 days (also reported as 2 days) after she received a small pox vaccination to the left arm prior to deployment. The patient noted a painful supraclavicular lymph node enlargement on the left. She noted having occasional chest pressure and cough without any sputum production plus night sweat. She denies fever, chills, vomiting, illicit drug use or recent travel. The patient was admitted to the cardiology service for the management of a suspected myopericarditis. Her cardiac enzymes were trended and all three sets were negative for acute coronary event. An echocardiogram and electrocardiogram were normal. The patient was started on low dose non-steroidal anti-inflammatory. The outcome was reported as unknown. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: SMALL, TD, SMALL, TTOX, ANTH, SMALL, TDAP, VARCEL, SMALL, TDAP, SMALL, TDAP
Symptoms: Echocardiogram normal, Electrocardiogram normal, Pericardial disease, Troponin I
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID# 387275. A 26 year-old female patient received the following vaccinations on 05 April 2010: ACAM2000 (lot number VV04003A), a right arm intramuscular injection of BOOSTRIX (lot number C3382AA). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no past medical history and no illness at the time of vaccination. She presented to the Emergency Room (ER) for shortness of breath (SOB) and orthopnea, 9 days (also reported as 2 days) after she received a small pox vaccination to the left arm prior to deployment. The patient noted a painful supraclavicular lymph node enlargement on the left. She noted having occasional chest pressure and cough without any sputum production plus night sweat. She denies fever, chills, vomiting, illicit drug use or recent travel. The patient was admitted to the cardiology service for the management of a suspected myopericarditis. Her cardiac enzymes were trended and all three sets were negative for acute coronary event. An echocardiogram and electrocardiogram were normal. The patient was started on low dose non-steroidal anti-inflammatory. The outcome was reported as unknown. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: SMALL, TD, SMALL, TTOX, ANTH, SMALL, TDAP, VARCEL, SMALL, TDAP, SMALL, TDAP
Symptoms: Cardiac enzymes normal, Chest discomfort, Cough, Dyspnoea, Echocardiogram normal
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID# 387275. A 26 year-old female patient received the following vaccinations on 05 April 2010: ACAM2000 (lot number VV04003A), a right arm intramuscular injection of BOOSTRIX (lot number C3382AA). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no past medical history and no illness at the time of vaccination. She presented to the Emergency Room (ER) for shortness of breath (SOB) and orthopnea, 9 days (also reported as 2 days) after she received a small pox vaccination to the left arm prior to deployment. The patient noted a painful supraclavicular lymph node enlargement on the left. She noted having occasional chest pressure and cough without any sputum production plus night sweat. She denies fever, chills, vomiting, illicit drug use or recent travel. The patient was admitted to the cardiology service for the management of a suspected myopericarditis. Her cardiac enzymes were trended and all three sets were negative for acute coronary event. An echocardiogram and electrocardiogram were normal. The patient was started on low dose non-steroidal anti-inflammatory. The outcome was reported as unknown. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: SMALL, TD, SMALL, TTOX, ANTH, SMALL, TDAP, VARCEL, SMALL, TDAP, SMALL, TDAP
Symptoms: Electrocardiogram normal, Lymph node pain, Lymphadenopathy, Myopericarditis, Night sweats
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID# 387275. A 26 year-old female patient received the following vaccinations on 05 April 2010: ACAM2000 (lot number VV04003A), a right arm intramuscular injection of BOOSTRIX (lot number C3382AA). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no past medical history and no illness at the time of vaccination. She presented to the Emergency Room (ER) for shortness of breath (SOB) and orthopnea, 9 days (also reported as 2 days) after she received a small pox vaccination to the left arm prior to deployment. The patient noted a painful supraclavicular lymph node enlargement on the left. She noted having occasional chest pressure and cough without any sputum production plus night sweat. She denies fever, chills, vomiting, illicit drug use or recent travel. The patient was admitted to the cardiology service for the management of a suspected myopericarditis. Her cardiac enzymes were trended and all three sets were negative for acute coronary event. An echocardiogram and electrocardiogram were normal. The patient was started on low dose non-steroidal anti-inflammatory. The outcome was reported as unknown. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: SMALL, TD, SMALL, TTOX, ANTH, SMALL, TDAP, VARCEL, SMALL, TDAP, SMALL, TDAP
Symptoms: Orthopnoea
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID# 387275. A 26 year-old female patient received the following vaccinations on 05 April 2010: ACAM2000 (lot number VV04003A), a right arm intramuscular injection of BOOSTRIX (lot number C3382AA). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no past medical history and no illness at the time of vaccination. She presented to the Emergency Room (ER) for shortness of breath (SOB) and orthopnea, 9 days (also reported as 2 days) after she received a small pox vaccination to the left arm prior to deployment. The patient noted a painful supraclavicular lymph node enlargement on the left. She noted having occasional chest pressure and cough without any sputum production plus night sweat. She denies fever, chills, vomiting, illicit drug use or recent travel. The patient was admitted to the cardiology service for the management of a suspected myopericarditis. Her cardiac enzymes were trended and all three sets were negative for acute coronary event. An echocardiogram and electrocardiogram were normal. The patient was started on low dose non-steroidal anti-inflammatory. The outcome was reported as unknown. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Angiogram pulmonary normal, Basophil count decreased, Basophil percentage decreased, Blood creatine phosphokinase MB increased, Blood creatine phosphokinase normal
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: C-reactive protein increased, Chest X-ray normal, Chest discomfort, Chest pain, Computerised tomogram normal
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Differential white blood cell count, Dyspnoea, Echocardiogram normal, Eosinophil count decreased, Eosinophil count normal
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Haematocrit normal, Haemoglobin normal, Headache, Laboratory test abnormal, Lymphocyte count normal
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Lymphocyte percentage decreased, Mean cell haemoglobin concentration normal, Mean cell haemoglobin increased, Mean cell volume normal, Mean platelet volume decreased
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.